Stem Cell Therapy in Retinal Diseases?

Overview

Journal Rev Bras Hematol Hemoter

Publisher Elsevier

Specialty Hematology

Date 2012 Oct 11

PMID 23049424

Citations 2

Authors

Rubens Camargo Siqueira

Affiliations

Soon will be listed here.

Citing Articles

Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.

Nguyen X, Moekotte L, Plomp A, Bergen A, van Genderen M, Boon C Int J Mol Sci. 2023; 24(8).

PMID: 37108642 PMC: 10139437. DOI: 10.3390/ijms24087481.

Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa.

Tuekprakhon A, Sangkitporn S, Trinavarat A, Pawestri A, Vamvanij V, Ruangchainikom M Stem Cell Res Ther. 2021; 12(1):52.

PMID: 33422139 PMC: 7796606. DOI: 10.1186/s13287-020-02122-7.

References

Cheng A, Yau T . Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. Semin Thorac Cardiovasc Surg. 2008; 20(2):94-101. DOI: 10.1053/j.semtcvs.2008.04.003. View

Wang S, Lu B, Girman S, Duan J, McFarland T, Zhang Q . Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS One. 2010; 5(2):e9200. PMC: 2821411. DOI: 10.1371/journal.pone.0009200. View

Sackett D, Rosenberg W, Gray J, Haynes R, Richardson W . Evidence based medicine: what it is and what it isn't. BMJ. 1996; 312(7023):71-2. PMC: 2349778. DOI: 10.1136/bmj.312.7023.71. View

Siqueira R, Voltarelli J, Messias A, Jorge R . Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells. Arq Bras Oftalmol. 2011; 73(5):474-9. DOI: 10.1590/s0004-27492010000500019. View

Cook D, Guyatt G, Laupacis A, Sackett D, Goldberg R . Clinical recommendations using levels of evidence for antithrombotic agents. Chest. 1995; 108(4 Suppl):227S-230S. DOI: 10.1378/chest.108.4_supplement.227s. View

Wollert K, Meyer G, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004; 364(9429):141-8. DOI: 10.1016/S0140-6736(04)16626-9. View

Castanheira P, Torquetti L, Nehemy M, Goes A . Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats. Arq Bras Oftalmol. 2008; 71(5):644-50. DOI: 10.1590/s0004-27492008000500007. View

Sheffield V, Stone E . Genomics and the eye. N Engl J Med. 2011; 364(20):1932-42. DOI: 10.1056/NEJMra1012354. View

Johnson T, Bull N, Hunt D, Marina N, Tomarev S, Martin K . Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci. 2009; 51(4):2051-9. PMC: 2868400. DOI: 10.1167/iovs.09-4509. View

10.

MacLaren R, Pearson R . Stem cell therapy and the retina. Eye (Lond). 2007; 21(10):1352-9. DOI: 10.1038/sj.eye.6702842. View

11.

Manser R, Walters E . What is evidence-based medicine and the role of the systematic review: the revolution coming your way. Monaldi Arch Chest Dis. 2001; 56(1):33-8. View

12.

Siqueira R . [Autologous transplantation of retinal pigment epithelium in age related macular degeneration]. Arq Bras Oftalmol. 2009; 72(1):123-30. DOI: 10.1590/s0004-27492009000100027. View

13.

Schwartz S, Hubschman J, Heilwell G, Franco-Cardenas V, Pan C, Ostrick R . Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012; 379(9817):713-20. DOI: 10.1016/S0140-6736(12)60028-2. View

14.

Yue F, Johkura K, Shirasawa S, Yokoyama T, Inoue Y, Tomotsune D . Differentiation of primate ES cells into retinal cells induced by ES cell-derived pigmented cells. Biochem Biophys Res Commun. 2010; 394(4):877-83. DOI: 10.1016/j.bbrc.2010.03.008. View

15.

Otani A, Dorrell M, Kinder K, Moreno S, Nusinowitz S, Banin E . Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest. 2004; 114(6):765-74. PMC: 516263. DOI: 10.1172/JCI21686. View

16.

Lanza R, Rosenthal N . The stem cell challenge. Sci Am. 2004; 290(6):92-9. DOI: 10.1038/scientificamerican0604-92. View

17.

Baker P, Brown G . Stem-cell therapy in retinal disease. Curr Opin Ophthalmol. 2009; 20(3):175-81. DOI: 10.1097/icu.0b013e328329b5f2. View

18.

Siqueira R, Messias A, Voltarelli J, Scott I, Jorge R . Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011; 31(6):1207-14. DOI: 10.1097/IAE.0b013e3181f9c242. View

19.

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

20.

Meyer J, Katz M, Maruniak J, Kirk M . Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells. 2005; 24(2):274-83. PMC: 3381839. DOI: 10.1634/stemcells.2005-0059. View